Literature DB >> 17075026

Effectiveness of blood pressure control outside the medical setting.

José R Banegas1, Julián Segura, Javier Sobrino, Fernando Rodríguez-Artalejo, Alejandro de la Sierra, Juan J de la Cruz, Manuel Gorostidi, Antonio Sarría, Luis M Ruilope.   

Abstract

We studied the effectiveness of blood pressure (BP) control outside the clinic by using ambulatory BP monitoring (ABPM) among a large number of hypertensive subjects treated in primary care centers across Spain. The sample consisted of 12 897 treated hypertensive subjects who had indications for ABPM. Office-based BP was calculated as the average of 2 readings. Twenty-four-hour ABPM was then performed using a SpaceLabs 90207 monitor under standardized conditions. A total of 3047 patients (23.6%) had their office BP controlled, and 6657 (51.6%) were controlled according to daytime ABPM. The proportion of office resistance or underestimation of patients' BP control by physicians in the office (office BP >or=140/90 mm Hg and average daytime ambulatory BP <135/85 mm Hg) was 33.4%, and the proportion of isolated office control or overestimation of control (office BP <140/90 mm Hg and average daytime ambulatory BP >or=135/85 mm Hg) was 5.4%. BP control was more frequently underestimated in patients who were older, female, obese, or with morning BP determination than in their counterparts. BP control was more frequently overestimated in those who were younger, male, nonobese, smokers, or with evening BP determination. Ambulatory-based hypertension control was far better than office-based hypertension control. This conveys an encouraging message to clinicians, namely that they are actually doing better than is evidenced by office-based data. However, the burden of underestimation and overestimation of BP control at the office is still remarkable. Physicians should be aware that the likelihood of misestimating BP control is higher in some hypertensive subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075026     DOI: 10.1161/01.HYP.0000250557.63490.55

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  26 in total

Review 1.  Detection and treatment of resistant hypertension.

Authors:  Julian Segura; Alejandro de la Sierra; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

2.  [Blood pressure control in a hypertensive population when measurements are performed in the clinic or self-monitoring by the patient].

Authors:  Francisco J Félix-Redondo; Daniel Fernández-Bergés; José Ríos-Rivera; José F Pérez-Castán; José I Valiente-Rubio; Luis M Molina-Martínez
Journal:  Aten Primaria       Date:  2009-02-03       Impact factor: 1.137

3.  Role of metabolic syndrome components in human immunodeficiency virus-associated stroke.

Authors:  Beau M Ances; Archana Bhatt; Florin Vaida; Debralee Rosario; Terry Alexander; Jennifer Marquie-Beck; Ronald J Ellis; Scott Letendre; Igor Grant; J Allen McCutchan
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

4.  Heart rate and heart rate variability in resistant versus controlled hypertension and in true versus white-coat resistance.

Authors:  A de la Sierra; D A Calhoun; E Vinyoles; J R Banegas; J J de la Cruz; M Gorostidi; J Segura; L M Ruilope
Journal:  J Hum Hypertens       Date:  2014-01-09       Impact factor: 3.012

Review 5.  Prevalence of white-coat and masked hypertension in national and international registries.

Authors:  Manuel Gorostidi; Ernest Vinyoles; José R Banegas; Alejandro de la Sierra
Journal:  Hypertens Res       Date:  2014-10-16       Impact factor: 3.872

6.  Hypertension control: population surveys vs clinical studies.

Authors:  J R Banegas; F Rodríguez-Artalejo
Journal:  J Hum Hypertens       Date:  2015-02-12       Impact factor: 3.012

7.  Trends in time to confirmation and recognition of new-onset hypertension, 2002-2006.

Authors:  Joe V Selby; Janelle Lee; Bix E Swain; Heather M Tavel; P Michael Ho; Karen L Margolis; Patrick J O'Connor; Lawrence Fine; Julie A Schmittdiel; David J Magid
Journal:  Hypertension       Date:  2010-08-23       Impact factor: 10.190

Review 8.  The importance of 24-hour ambulatory blood pressure monitoring in patients at risk of cardiovascular events.

Authors:  Josep Redon
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-03-27

9.  Recent advances in the management of hypertension.

Authors:  José Antonio García-Donaire; Luis M Ruilope
Journal:  F1000 Med Rep       Date:  2010-03-15

Review 10.  White-coat hypertension should not be treated in subjects with diabetes.

Authors:  Michael Bursztyn; Iddo Z Ben-Dov
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.